Whilst it is likely that alteration of CD1d expression will in turn enable tumour escape from NKT cell-mediated immunosurveillance, it is also possible that altered expression of CD1d contributes to metabolic alterations in tumour cells by regulating CD36 functions. This evidence concerns the gene CD1D and neoplasm.